CVS Health reported third quarter 2026 total revenues of $108.4 billion, up 5.4% year-over-year, alongside GAAP diluted EPS of $1.68. The company raised its full-year 2026 guidance to reflect strong performance across its Health Care Benefits and Pharmacy & Consumer Wellness segments.